Literature DB >> 15639484

Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.

Yasuo Sugano1, Toshihisa Anzai, Tsutomu Yoshikawa, Yuichiro Maekawa, Takashi Kohno, Keitaro Mahara, Kotaro Naito, Satoshi Ogawa.   

Abstract

OBJECTIVE: In the early phase after transmural myocardial infarction (MI), the infarcted myocardium undergoes replacement by scar tissue, which is essential for preserving the structural integrity of the infarcted tissue. Transforming growth factor (TGF)-beta1, which is known as a fibrotic cytokine, plays a pivotal role in the reparative fibrosis after MI. It is reported that granulocyte colony-stimulating factor (G-CSF) can accelerate wound healing. The aim of our study was to investigate the effect of G-CSF on early ventricular expansion after MI.
METHODS: MI was induced by ligation of the left coronary artery in male Wistar rats. G-CSF (20 microg/kg/day, MI-GCSF) or saline (MI-saline) was injected subcutaneously 3 h after MI and every 24 h thereafter for 7 days. Hemodynamic and echocardiographic studies were performed at 14 days. Expression of TGF-beta1 and procollagen type I and type III mRNA in both the infarcted and noninfarcted areas was studied by quantitative RT-PCR at 1, 3, 7, and 14 days after MI. Histological studies were performed at 7 days.
RESULTS: MI-GCSF had higher LV max dP/dt, lower LV end-diastolic pressure, and smaller LV end-diastolic and end-systolic dimensions compared to MI-saline. Infarct size was not different between MI-GCSF and MI-saline. Expression of TGF-beta1 mRNA in the infarcted area at 3 days was significantly higher in MI-GCSF than in MI-saline. Expression of procollagen type I and type III mRNA in the infarcted area at 3 days was higher in MI-GCSF compared to MI-saline, and the peak mRNA levels were earlier in MI-GCSF. In the noninfarcted area, there was no difference in TGF-beta1 mRNA expression between MI-GCSF and MI-saline. Histologically, collagen accumulation in the infarcted area at 7 days was more prominent in MI-GCSF than in MI-saline.
CONCLUSION: G-CSF treatment improves early post-infarct ventricular expansion through promotion of reparative collagen synthesis in the infarcted area, suggesting some beneficial effect of G-CSF on the infarct healing process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639484     DOI: 10.1016/j.cardiores.2004.10.008

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  21 in total

Review 1.  Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction.

Authors:  Hiroyuki Takano; Yingjie Qin; Hiroshi Hasegawa; Kazutaka Ueda; Yuriko Niitsuma; Masashi Ohtsuka; Issei Komuro
Journal:  J Mol Med (Berl)       Date:  2006-01-17       Impact factor: 4.599

Review 2.  Cardiac repair--fact or fancy?

Authors:  E Leontiadis; A Manginas; D V Cokkinos
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

Review 3.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

4.  Clenbuterol plus granulocyte colony-stimulating factor regulates stem/progenitor cell mobilization and exerts beneficial effect by increasing neovascularization in rats with heart failure.

Authors:  Toshikazu D Tanaka; Jordan J Lancaster; Elizabeth Juneman; Joseph J Bahl; Steven Goldman
Journal:  J Card Fail       Date:  2013-07       Impact factor: 5.712

5.  Granulocyte colony-stimulating factor does not enhance recruitment of bone marrow-derived cells in rats with acute myocardial infarction.

Authors:  Daisuke Sato; Hajime Otani; Masanori Fujita; Takayuki Shimazu; Kei Yoshioka; Chiharu Enoki; Naoki Minato; Toshiji Iwasaka
Journal:  Exp Clin Cardiol       Date:  2012-09

6.  In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.

Authors:  Meifeng Xu; Ryota Uemura; Ying Dai; Yigang Wang; Zeeshan Pasha; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2006-12-20       Impact factor: 5.000

Review 7.  Protein therapeutics for cardiac regeneration after myocardial infarction.

Authors:  Vincent F M Segers; Richard T Lee
Journal:  J Cardiovasc Transl Res       Date:  2010-07-07       Impact factor: 4.132

Review 8.  Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.

Authors:  Santosh K Sanganalmath; Ahmed Abdel-Latif; Roberto Bolli; Yu-Ting Xuan; Buddhadeb Dawn
Journal:  Basic Res Cardiol       Date:  2011-05-04       Impact factor: 17.165

Review 9.  Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.

Authors:  Marton Vertesaljai; Zsolt Piroth; Geza Fontos; Gyorgy Andreka; Gusztav Font; Gergely Szantho; Sandor Lueff; Marienn Reti; Tamas Masszi; Laszlo Ablonczy; Eszter D Juhasz; Tamas Simor; Mark S Turner; Peter Andreka
Journal:  Heart Fail Rev       Date:  2007-08-01       Impact factor: 4.214

10.  Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.

Authors:  Hajime Morimoto; Masafumi Takahashi; Yuji Shiba; Atsushi Izawa; Hirohiko Ise; Minoru Hongo; Kiyohiko Hatake; Kazuo Motoyoshi; Uichi Ikeda
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.